Dan S. Gombos, M.D., FACS

Local Presentations

1. 2026. Ophthalmic Toxicities of Targeted Therapies. Conference. 40th Annual Baylor Cullen Course. Houston, Texas, US.
2. 2026. Retinoblastoma Pre-) Neonatal to Adult Management. Conference. 40th Annual Baylor Cullen Course. Houston, Texas, US.
3. 2025. Tips and Tricks for Your Neck Enucleation. Conference. 39th Annual Baylor Cullen Course. Houston, Texas, US.
4. 2025. Whack a Mole: A Closer Look at Pigmented Conjunctival Lesions. Conference. 39th Annual Baylor Cullen Course. Houston, Texas, US.
5. 2022. Uveal Melanoma: The Role of Prognostication Based on Size, Staging, and FNAB. Conference. 36th Annual Baylor Cullen Course. Houston, Texas, US.
6. 2022. The Role of IAC and Intravitreal Chemotherapy in the Management of Retinoblastoma. Conference. 36th Annual Baylor Cullen Course. Houston, Texas, US.
7. 2021. Ocular Tumors. Conference. 35th Annua Baylor Cullen Course. Houston, TX, US.
8. 2021. Ocular Toxicities from Targeted Bladder Cancer Therapies. Conference. Ocular Toxicities from Targeted Bladder Cancer Therapies. Houston, TX, US.
9. 2020. Von Hippel-Lindau Screening Guidelines. Conference. 34th Annual Baylor Cullen Course. Houston, TX, US.
10. 2019. New Therapeutic Options for Primary and Metastatic Uveal Melanoma. Conference. 33rd Annual Baylor Cullen Course. Houston, Texas, US.
11. 2017. Advances & Controversies in the Management of Retinoblastoma 2017. Conference. Advances & Controversies in the Management of Retinoblastoma 2017. Houston, TX, US.
12. 2013. Ocular Melanoma 101. Conference. Ocular Melanoma 101. Houston, TX, US.
13. 2013. Management & Treatment of Intraocular Tumors. Conference. Management & Treatment of Intraocular Tumors. Houston, TX, US.
14. 2013. Diagnosis & Treatment of phakomatoses. Conference. Diagnosis & Treatment of phakomatoses. Houston, TX, US.
15. 2012. Latest Advances in the Ophthalmic Management of VHL. Conference. Latest Advances in the Ophthalmic Management of VHL. Houston, TX, US.
16. 2011. Advances in Treatment of Eye Lesions in VHL. Conference. Advances in Treatment of Eye Lesions in VHL. Houston, TX, US.
17. 2011. A Multi-Centered Model for the Management of Retinoblastoma: The Retinoblastoma Center of Houston. Conference. A Multi-Centered Model for the Management of Retinoblastoma: The Retinoblastoma Center of Houston. Houston, TX, US.
18. 2011. Management of Retinoblastoma in 2011. Conference. Management of Retinoblastoma in 2011. Houston, TX, US.
19. 2010. Ultrasound of Eye Cancers. Conference. Ultrasound of Eye Cancers. Houston, TX, US.
20. 2010. Leukocoria in an infant. Conference. Leukocoria in an infant. Houston, TX, US.
21. 2009. Ocular Manifestations of Cancer Genetic Syndromes. Conference. Ocular Manifestations of Cancer Genetic Syndromes. Houston, TX, US.
22. 2006. Controversies in the Management of Retinoblastoma. Conference. Controversies in the Management of Retinoblastoma. Houston, TX, US.
23. 2005. International Survey of Retinoblastoma Therapy Among Ocular Oncology Centers. Conference. International Survey of Retinoblastoma Therapy Among Ocular Oncology Centers. Houston, TX, US.
24. 2005. Systemic Malignancies Metastatic to the Conjunctiva. Conference. Systemic Malignancies Metastatic to the Conjunctiva. Houston, TX, US.
25. 2002. Eye cancers: Surviving and beating the odds. Conference. Eye cancers: Surviving and beating the odds. Houston, TX, US.

Regional Presentations

1. 2025. Curing Uveal Melanoma. Invited. Annual C.S. O'Brien Professorship and Tulane Eye Alumni Day. New Orleans, Louisiana, US.
2. 2025. 2025 Update Ocular Oncology. Invited. Stanford University School of Medicine Resident Lecture 2025. Palo Alto, California, US.
3. 2025. Curing Uveal Melanoma. Invited. Stanford University School of Medicine - Grand Rounds. Palo Alto, California, US.
4. 2021. Drug Toxicities from Cancer Therapies. Conference. Drug Toxicities from Cancer Therapies, US.
5. 2019. Indications for Intra-Arterial Chemotherapy for Retinoblastoma. Conference. Indications for Intra-Arterial Chemotherapy for Retinoblastoma. Atlanta, GA, US.
6. 2018. A Child with Leukocoria & An Intraocular Mass. Conference. A Child with Leukocoria & An Intraocular Mass. Austin, TX, US.
7. 2016. A Case of Two Melanomas. Conference. A Case of Two Melanomas. Dallas, TX, US.
8. 2015. Transcorneal vitrectomy in setting of retinoblastoma. Conference. Transcorneal vitrectomy in setting of retinoblastoma. Austin, TX, US.
9. 2014. Adjuvant Ipilimumab for high-risk uveal melanoma follow up. Conference. Adjuvant Ipilimumab for high-risk uveal melanoma follow up. Philadelphia, PA, US.
10. 2014. Metastatic melanoma in a young woman. Conference. Metastatic melanoma in a young woman. Philadelphia, PA, US.
11. 2014. The Genetics of Melanoma. Conference. The Genetics of Melanoma. Austin, TX, US.
12. 2014. Update on the Management of Uveal Tumors. Conference. Update on the Management of Uveal Tumors. Fort Worth, TX, US.
13. 2013. Choroidal Metastasis From Thyroid Cancer. Conference. Choroidal Metastasis From Thyroid Cancer. Austin, TX, US.
14. 2013. Genetics in Ocular Oncology. Conference. Genetics in Ocular Oncology. San Antonio, TX, US.
15. 2012. Retinoblastoma 2012: Clinical Challenges and Future Direction. Conference. Retinoblastoma 2012: Clinical Challenges and Future Direction. Fort Worth, TX, US.
16. 2007. New Approaches and Treatment Option for Patients with Intraocular Tumors. Conference. New Approaches and Treatment Option for Patients with Intraocular Tumors. Dallas, TX, US.
17. 2005. Estimating the incidence of retinoblastoma in Texas. Conference. Estimating the incidence of retinoblastoma in Texas. Grapevine, TX, US.
18. 2004. New classification schemes for the staging of intraocular retinoblastomas. Conference. New classification schemes for the staging of intraocular retinoblastomas. Austin, TX, US.
19. 2004. Alternatives to the collaborative ocular melanoma study (COMS) plaque-ocular brachytherapy with ruthenium. Conference. Alternatives to the collaborative ocular melanoma study (COMS) plaque-ocular brachytherapy with ruthenium. Austin, TX, US.
20. 2003. Management of orbital cellulitis in the cancer patient: The MD Anderson approach. Conference. Management of orbital cellulitis in the cancer patient: The MD Anderson approach. San Antonio, TX, US.
21. 2003. Vitreous relapse following primary chemotherapy for retinoblastoma. Conference. Vitreous relapse following primary chemotherapy for retinoblastoma. San Antonio, TX, US.
22. 2002. Retinoblastoma: Advances and failures with primary chemotherapy. Conference. Retinoblastoma: Advances and failures with primary chemotherapy. Dallas, TX, US.
23. 2001. Ocular side effects of chemotherapy. Conference. Ocular side effects of chemotherapy. Wharton, TX, US.
24. 1999. Cholesterosis following chemoreduction and radiation therapy for bilateral retinoblastoma. Conference. Cholesterosis following chemoreduction and radiation therapy for bilateral retinoblastoma. San Francisco, CA, US.
25. 1999. Choroidal melanoma during pregnancy. Conference. Choroidal melanoma during pregnancy. San Francisco, CA, US.
26. 1999. Pigmented tumors of the conjunctiva. Conference. Pigmented tumors of the conjunctiva. San Francisco, CA, US.
27. 1995. Retinoblastoma 1995. Conference. Retinoblastoma 1995. San Diego, CA, US.

National Presentations

1. 2026. Drug resistance mechanisms in uveal melanoma. Poster. American Association for Cancer Research (AACR) Annual Meeting 2026. San Diego, California, US.
2. 2025. Practical Ocular Oncology for the Comprehensive Ophthalmologist: WHAT YOU SHOULD KNOW. Invited. American Academy of Ophthalmology. Orlanda, Florida, US.
3. 2025. Pediatric Oncology/Retinoblastoma - The Future is Worth It. All the Pain, All the Tears - The Future of Oncology is Worth the Fight. Invited. American Academy of Ophthalmology. Orlando, Florida, US.
4. 2025. Poster Presentation: Epiretinal Membranes are Associated to Adverse Ocular Outcome in Retinoblastoma. Poster. ARVO 2025, California, US.
5. 2024. Practice Pearls for Intraocular Tumors. Invited. American Academy of Ophthalmology. Chicago, IL, US.
6. 2023. Clinical trial development in the era of immune mediated and targeted therapy: Screening and plannin for therapy induced ocular toxicity. Invited. Innovate Ocular Oncology. San Francisco, CA, US.
7. 2023. It's in the liquid_How ancillary studies in clinical trials will cure eye cancer. Invited. Innovate Ocular Oncology. San Francisco, CA, US.
8. 2023. Challenges in prospective clinical trials in pediatric ocular oncology. Invited. Innovate Ocular Oncology. San Francisco, CA, US.
9. 2023. Zimmerman Lecture: Liquid Biopsy & Personalized Medicine: The keys that will cure ocular cancer. Invited. American Academy of Ophthalmology. San Francisco, CA, US.
10. 2023. Practical Ocular Oncology for the Comprehensive Ophthalmologist: What You Should Know. Invited. American Academy of Ophthalmology. San Francisco, CA, US.
11. 2023. Poster Presentation: Targeted Cancer Therapy Associated Optic Neuropathy at a U.S. Tertiary Cancer Center. Conference. Poster Presentation: Targeted Cancer Therapy Associated Optic Neuropathy at a U.S. Tertiary Cancer Center. Orlando, FL, US.
12. 2022. Novel Treatments and Future Directions. Conference. Novel Treatments and Future Directions. Chicago, IL, US.
13. 2022. Retinoblastoma 2022: What Has Changed and What Has Not?. Conference. Retinoblastoma 2022: What Has Changed and What Has Not?. Chicago, IL, US.
14. 2022. Practical Ocular Oncology for the Comprehensive Ophthalmologist: What You Should Know. Conference. Practical Ocular Oncology for the Comprehensive Ophthalmologist: What You Should Know. Chicago, IL, US.
15. 2022. The VISION (Virtual Information System to Improve Outcomes and Networks) Platform for ocular (uveal & conjunctival) melanoma. Conference. The VISION (Virtual Information System to Improve Outcomes and Networks) Platform for ocular (uveal & conjunctival) melanoma. Chicago, IL, US.
16. 2022. Poster Presentation: MEK/BRAF Inhibitor- Associated Retinopathy at a U.S. Tertiary Cancer Center. Conference. Poster Presentation: MEK/BRAF Inhibitor- Associated Retinopathy at a U.S. Tertiary Cancer Center. Chicago, IL, US.
17. 2022. Podium Presentation: MEK/BRAF Inhibitors Associated Retinopathy at a U.S. Tertiary Cancer Center. Conference. Podium Presentation: MEK/BRAF Inhibitors Associated Retinopathy at a U.S. Tertiary Cancer Center. Chicago, IL, US.
18. 2022. Risk factors & management of metastatic. Conference. Risk factors & management of metastatic, US.
19. 2022. Bilateral Neuroretinitis in a Pediatric Patient: Which One Is It?. Conference. Retina Case Conference. New York, NY, US.
20. 2022. Closing Ceremony. Conference. Closing Ceremony. International Society of Ocular Oncology, US.
21. 2022. Lessons Learned from ADC Trials. Conference. Lessons Learned from ADC Trials, US.
22. 2022. Poster Presentation: Visual Outcomes in Neurofibromatosis Type-1 Patients with Optic Pathway at a Tertiary Cancer Center. Conference. Poster Presentation: Visual Outcomes in Neurofibromatosis Type-1 Patients with Optic Pathway at a Tertiary Cancer Center, US.
23. 2022. Poster Presentation: Spontaneous Debulking of a Large Skull Base Mass: Case Report. Conference. Poster Presentation: Spontaneous Debulking of a Large Skull Base Mass: Case Report, US.
24. 2021. Poster Presentation: Highlights on Ocular Adverse Effects of Checkpoint Inhibitor Immunotherapy at U.S. Tertiary Cancer Center. Conference. Zoom Presentation. New Orleans, LA, US.
25. 2021. Visual Outcomes in Neurofibromatosis Type 1 Patients with Optic Pathways Gliomas at a U.S. Tertiary Cancer Center. Conference. Zoom Presentation. New Orleans, LA, US.
26. 2021. Podium Presentation: Highlights on Ocular Adverse Effects of Checkpoint Inhibitor Immunotherapy at US Tertiary Cancer Center. Conference. Podium Presentation: Highlights on Ocular Adverse Effects of Checkpoint Inhibitor Immunotherapy at US Tertiary Cancer Center. New Orleans, LA, US.
27. 2021. Ophthalmoplegia Associated with Extramedullary Multiple Myeloma. Conference. Zoom Presentation, US.
28. 2021. Retinoblastoma. Conference. Zoom Presentation, US.
29. 2021. Systemic Chemotherapy in Targeted Chemotherapy Era: Is there still any role. Conference. Retinoblastoma Webinar, US.
30. 2021. Is fine needle biopsy necessary?. Conference. Zoom Presentation, US.
31. 2021. Poster Presentation: Successful Tumor-Infiltrating Lymphocyte Growth from Uveal Melanoma Using a 3-Signal Method. Conference. Poster Presentation: Successful Tumor-Infiltrating Lymphocyte Growth from Uveal Melanoma Using a 3-Signal Method, US.
32. 2021. Poster Presentation: Phase I Safety and Efficacy Study of Autophagy Inhibition with Hydroxychloronquine to Augment the Antiproliferative and Biological Effects of Preoperative Palbociclib plus Letrozole for Estrogen Receptor-Positive, HER2-negative Metastatic Breast Cancer (MBC). Conference. Poster Presentation: Phase I Safety and Efficacy Study of Autophagy Inhibition with Hydroxychloronquine to Augment the Antiproliferative and Biological Effects of Preoperative Palbociclib plus Letrozole for Estrogen Receptor-Positive, HER2-negative Metastatic Breast Cancer (MBC), US.
33. 2021. Is Fine Needle Biopsy Necessary?. Conference. Zoom Presentation, US.
34. 2021. Poster Presentation: T-cell Lymphoma and the Unusual Infiltrative Optic Neuropathy. Conference. Zoom Presentation, US.
35. 2021. . Poster Presentation: Erdheim Chester Disease - Atypical Presentation and New Promising Treatmen. Conference. . Poster Presentation: Erdheim Chester Disease - Atypical Presentation and New Promising Treatmen, US.
36. 2021. T-cell Lymphomas and the Unusual Infiltrative Optic Neuropathy. Conference. T-cell Lymphomas and the Unusual Infiltrative Optic Neuropathy, US.
37. 2021. Poster Presentation: Not The Monster This Time. Conference. Zoom Presentation, US.
38. 2021. Poster Presentation: Atypical Presentation and New Promising Treatment. Conference. Zoom Presentation, US.
39. 2020. Tips in Diagnosing Atypical Presentations of Retinoblastoma. Conference. Webex Presentation, US.
40. 2020. Poster Presentation: The New 2020 Guidelines for Retinal Surveillance of Patients with VHL Disease: A New Approach. Conference. Webex Presentation, US.
41. 2020. Ocular Toxicity Profile of Targeted Cancer Therapy at a US Tertiary Cancer Center. Conference. Webex Presentation, US.
42. 2020. Ocular Oncology/Pathology 2020: Collaboration Now More Than Ever. Conference. Webex Presentation, US.
43. 2020. Systemic Oncology: An Update for Ophthalmologists. Conference. Webex Presentation, US.
44. 2020. AAO Course: Practical Ocular Oncology for the Comprehensive Ophthalmologist: What You Should Know. Conference. Webex Presentation, US.
45. 2020. The AAOOP's Response to the COVID-19 Pandemic. Conference. Webex Presentation, US.
46. 2020. Current Treatment of Uveal Melanoma. Conference. Webex Presentation, US.
47. 2020. Current Treatment of Intraocular lymphoma. Conference. Webex Presentation, US.
48. 2020. Using telemedicine for prospective clinical trials in ocular oncology. Conference. Webex Presentation, US.
49. 2020. Management of invasive conjunctival carcinoma. Conference. Webex Presentation, US.
50. 2020. AAOOP Course: Telepathology and oncology. Conference. Webex Presentation, US.
51. 2020. Oncology Guidelines During Covid-19. Conference. Webex Presentation, US.
52. 2019. Indications for Intra-Arterial Chemotherapy for Retinoblastoma- When to Do It. Conference. Indications for Intra-Arterial Chemotherapy for Retinoblastoma- When to Do It. Atlanta, GA, US.
53. 2019. AAO Course: Retinoblastoma 2016: What has Changed and What Has Not?. Conference. AAO Course: Retinoblastoma 2016: What has Changed and What Has Not?. San Francisco, CA, US.
54. 2019. Diagnosis of retinoblastoma through Imaging and Structural Features. Conference. Diagnosis of retinoblastoma through Imaging and Structural Features. Salt Lake City, UT, US.
55. 2019. Poster Presentation: Phase II Study of Ipilimumab and Nivolumab in Metastatic Uveal Melanoma. Conference. Poster Presentation: Phase II Study of Ipilimumab and Nivolumab in Metastatic Uveal Melanoma. Chicago, IL, US.
56. 2019. Adjuvant Ipilimumab in Uveal Melanoma. Conference. Adjuvant Ipilimumab in Uveal Melanoma. London.
57. 2019. Tumor infiltrating lymphocyte (TIL) harvest and ex vivo expansion from primary and metastatic uveal melanoma tumors: the MD Anderson experience. Conference. Tumor infiltrating lymphocyte (TIL) harvest and ex vivo expansion from primary and metastatic uveal melanoma tumors: the MD Anderson experience. Los Angeles, CA, US.
58. 2019. Comprehensive Retrospective Evaluation of 6 years of Intra-arterial Chemotherapy for Retinoblastoma with case by case correlation of angiographic findings with RetCam imaging. Conference. Comprehensive Retrospective Evaluation of 6 years of Intra-arterial Chemotherapy for Retinoblastoma with case by case correlation of angiographic findings with RetCam imaging. Los Angeles, CA, US.
59. 2019. Poster Presentation: Retinoblastoma Referral Patterns in Ethiopia. Conference. Poster Presentation: Retinoblastoma Referral Patterns in Ethiopia. Los Angeles, CA, US.
60. 2019. Quantity and quality of optic nerve invasion matters in Retinoblastoma. Conference. Quantity and quality of optic nerve invasion matters in Retinoblastoma. Los Angeles, CA, US.
61. 2019. Chemoplaque (sustained-release topotecan episcleral device) for retinoblastoma: Opportunity for rapid clinical evaluation of toxicity and efficacy to support safe eye salvage. Conference. Chemoplaque (sustained-release topotecan episcleral device) for retinoblastoma: Opportunity for rapid clinical evaluation of toxicity and efficacy to support safe eye salvage. Los Angeles, CA, US.
62. 2019. Spontaneous regression of malignant teratoid medulloepithelioma with massive maxillary and skull base recurrence. Conference. Spontaneous regression of malignant teratoid medulloepithelioma with massive maxillary and skull base recurrence. Los Angeles, CA, US.
63. 2019. Poster Presentation: Notched-Plaque Brachytherapy for Peripapillary Uveal Melanoma: Longterm Outcomes and Comparison of a Novel Loaded Plaque Technique versus Conventional Loading Strategy. Conference. Poster Presentation: Notched-Plaque Brachytherapy for Peripapillary Uveal Melanoma: Longterm Outcomes and Comparison of a Novel Loaded Plaque Technique versus Conventional Loading Strategy. Los Angeles, CA, US.
64. 2019. The CURE OM Patient-reported Registry for uveal and conjunctival melanoma. Conference. The CURE OM Patient-reported Registry for uveal and conjunctival melanoma. Los Angeles, CA, US.
65. 2019. Poster Presentation: Presence of Circulating tumor cells is an adverse risk factor for Early Stage Uveal Melanoma. Conference. Poster Presentation: Presence of Circulating tumor cells is an adverse risk factor for Early Stage Uveal Melanoma. Houston, TX, US.
66. 2018. AAO Course: Practical Ocular Oncology for the Comprehensive Ophthalmologist: What You Should Know. Conference. AAO Course: Practical Ocular Oncology for the Comprehensive Ophthalmologist: What You Should Know. Chicago, IL, US.
67. 2018. Clinical Indication for Diagnostic and Prognostic Biopsy of Intraocular Neoplasms. Conference. Clinical Indication for Diagnostic and Prognostic Biopsy of Intraocular Neoplasms. Chicago, IL, US.
68. 2018. There Is Consensus on the Use of Intra-arterial Chemotherapy or Unilateral Retinoblastoma. Conference. There Is Consensus on the Use of Intra-arterial Chemotherapy or Unilateral Retinoblastoma. Chicago, IL, US.
69. 2017. AAO Course: Practical Ocular Oncology for the Comprehensive Ophthalmologist: What You Should Know. Conference. AAO Course: Practical Ocular Oncology for the Comprehensive Ophthalmologist: What You Should Know. New Orleans, LA, US.
70. 2017. Survivors & Early and Late Screening. Conference. Survivors & Early and Late Screening. Washington, DC, US.
71. 2017. Informed Consent, Evidence Based Medicine & Technology. Conference. Informed Consent, Evidence Based Medicine & Technology. Washington, DC, US.
72. 2017. High Risk Features in RB. Conference. High Risk Features in RB. Washington, DC, US.
73. 2017. Patients with Probable High Risk Features by Clinical Presentation. Conference. Patients with Probable High Risk Features by Clinical Presentation. Arlington, VA, US.
74. 2016. AAO Course: What Do You Mean You Don't Know the Diagnosis? Surgical Pearls in Tissue Resection and Submission. Conference. AAO Course: What Do You Mean You Don't Know the Diagnosis? Surgical Pearls in Tissue Resection and Submission. Chicago, IL, US.
75. 2016. Clinical Presentation of Retinoblastoma. Conference. Clinical Presentation of Retinoblastoma. Chicago, IL, US.
76. 2016. Genetics and Management. Conference. Genetics and Management. Chicago, IL, US.
77. 2016. AAO Course: Practical Ocular Oncology for the Comprehensive Ophthalmologist: What You Should Know. Conference. AAO Course: Practical Ocular Oncology for the Comprehensive Ophthalmologist: What You Should Know. Chicago, IL, US.
78. 2016. Paper: Retinoblastoma: Documented Toxicities of Intra-arterial Chemotherapy. Conference. Paper: Retinoblastoma: Documented Toxicities of Intra-arterial Chemotherapy. Chicago, IL, US.
79. 2016. Ocular Oncology-Ophthalmology's Youngest and Oldest Subspecialty. Conference. Ocular Oncology-Ophthalmology's Youngest and Oldest Subspecialty. Philadelphia, PA, US.
80. 2015. Course: Practical Ocular Oncology for the Comprehensive Ophthalmologist: What You Should Know. Conference. Course: Practical Ocular Oncology for the Comprehensive Ophthalmologist: What You Should Know. Las Vegas, NV, US.
81. 2015. Retinoblastoma Center of Houston Approach. Conference. Retinoblastoma Center of Houston Approach. Las Vegas, NV, US.
82. 2015. Proton therapy for treatment of ocular tumors. Conference. Proton therapy for treatment of ocular tumors. Las Vegas, NV, US.
83. 2015. Late Presentation of Retinoblastoma in a Teen with Aicardi Syndrome. Conference. Late Presentation of Retinoblastoma in a Teen with Aicardi Syndrome. Las Vegas, NV, US.
84. 2015. A Histopathologic Pitfall in the Evaluation of Eyes with Retinoblastoma. Conference. A Histopathologic Pitfall in the Evaluation of Eyes with Retinoblastoma. Brewster, MA, US.
85. 2015. Melanoma Protocols and Retinoblastoma case report. Conference. Melanoma Protocols and Retinoblastoma case report. Philadelphia, PA, US.
86. 2015. Tumors - Retinoblastoma. Conference. Tumors - Retinoblastoma. Denver, CO, US.
87. 2014. AAO Course: Practical Ocular Oncology for the Comprehensive Ophthalmologist: What You Should Know. Conference. AAO Course: Practical Ocular Oncology for the Comprehensive Ophthalmologist: What You Should Know. Chicago, IL, US.
88. 2014. Retinoblastoma; Clinical Aspects. Conference. Retinoblastoma; Clinical Aspects. Chicago, IL, US.
89. 2013. AAO Course: Practical Ocular Oncology for the Comprehensive Ophthalmologist: What you should know. Conference. AAO Course: Practical Ocular Oncology for the Comprehensive Ophthalmologist: What you should know. New Orleans, LA, US.
90. 2013. Imaging for Tumors Related to the Eye and Orbit. Conference. Imaging for Tumors Related to the Eye and Orbit. New Orleans, LA, US.
91. 2013. Intraocular Burkitt's Lymphoma Responsive to Photodynamic Therapy. Conference. Intraocular Burkitt's Lymphoma Responsive to Photodynamic Therapy. New Orleans, LA, US.
92. 2013. Class 1A Metastasis in Uveal Melanoma: the MD Anderson Experience. Conference. Class 1A Metastasis in Uveal Melanoma: the MD Anderson Experience. Cleveland, OH, US.
93. 2013. Unusual immune-mediated adverse events in uveal melanoma patients receiving ipilimumab. Conference. Unusual immune-mediated adverse events in uveal melanoma patients receiving ipilimumab. Cleveland, OH, US.
94. 2013. Validation of histopathologic guidelines for the detection of high risk histopathologic features in retinoblastoma. Conference. Validation of histopathologic guidelines for the detection of high risk histopathologic features in retinoblastoma. Cleveland, OH, US.
95. 2013. Outcomes of Clear Corneal Endoscopic Vitrectomy for Vitreoretinal Complications following Successful Retinoblastoma Treatment. Conference. Outcomes of Clear Corneal Endoscopic Vitrectomy for Vitreoretinal Complications following Successful Retinoblastoma Treatment. Cleveland, OH, US.
96. 2012. Ocular Tumors: Evidence-Based Rationale for Treatment. Conference. American Association of Ophthalmic Oncologist and Pathologists. Chicago, IL, US.
97. 2012. The Evidence for Treatment of Ocular Adnexal Lymphoma. Conference. The Evidence for Treatment of Ocular Adnexal Lymphoma. Chicago, IL, US.
98. 2012. What the General Ophthalmologist Needs to Know About Cancer and its Complications: From Front to Back. Conference. What the General Ophthalmologist Needs to Know About Cancer and its Complications: From Front to Back. Chicago, IL, US.
99. 2012. Pediatric Leukocoria: All You Need to Know. Conference. Pediatric Leukocoria: All You Need to Know. Chicago, IL, US.
100. 2012. Quantitative Analysis of VEGF, and its receptor VEGFR-2 in Retinoblastoma Eyes with Neovascular Glaucoma and High. Conference. Northwestern Memorial Hospital. Chicago, IL, US.
101. 2012. Central Serous Retinopathy in Cancer Patients. Conference. Central Serous Retinopathy in Cancer Patients. Fort Lauderdale, FL, US.
102. 2012. Clinical Trials for Retinoblastoma: Present and Future. Conference. Clinical Trials for Retinoblastoma: Present and Future. Fort Lauderdale, FL, US.
103. 2011. What the General Ophthalmologist Needs to Know about Cancer and Its Complications: From Front to Back. Conference. What the General Ophthalmologist Needs to Know about Cancer and Its Complications: From Front to Back. Orlando, FL, US.
104. 2011. Poster Presentation, Retinoblastoma Associated Orbital Cellulitis. Conference. American Society of Ophthalmic Plastic and Reconstructive Surgery. Orlando, FL, US.
105. 2011. Pediatric Leukocoria: A Primer. Conference. Pediatric Leukocoria: A Primer. Orlando, FL, US.
106. 2011. Poster Presentation, Incidence and Management of Radiation-Induced Anophthalmic Socket Contracture in Patients with Uveal Melanoma. Conference. American Society of Ophthalmic Plastic and Reconstructive Surgery. Orlando, FL, US.
107. 2011. Poster Presentation, Microphthalmos with Orbital Cyst-Presentation , Radiography, and Management. Conference. American Society of Ophthalmic Plastic and Reconstructive Surgery. Orlando, FL, US.
108. 2011. Poster Presentation, Recurrence of Primary Intraocular Lymphoma Following Radiation and Chemotherapy. Conference. American Association of Ocular Oncology and Ocular Pathology. Orlando, FL, US.
109. 2011. Poster Presentation: Mutant Dependent Uveal Melanoma Sensitivity to MEK and PI3K Inhibitors. Conference. Poster Presentation: Mutant Dependent Uveal Melanoma Sensitivity to MEK and PI3K Inhibitors. Fort Lauderdale, FL, US.
110. 2011. Poster Presentation: Pathology and Management of Orbital Cysts seen in Microphthalmos. Conference. Poster Presentation: Pathology and Management of Orbital Cysts seen in Microphthalmos. Fort Lauderdale, FL, US.
111. 2010. Pediatric Leukocoria: A Primer. Conference. Pediatric Leukocoria: A Primer. Chicago, IL, US.
112. 2010. Children's Oncology Group: Evaluating Intra-arterial Chemotherapy for Retinoblastoma. Conference. Children's Oncology Group: Evaluating Intra-arterial Chemotherapy for Retinoblastoma. Chicago, IL, US.
113. 2010. A Proposed National Multi-Center Trial Administering Intra-Arterial Chemotherapy for Intraocular Retinoblastoma. Conference. American Association of Ophthalmic Pathologists. Chicago, IL, US.
114. 2010. Intraocular Neoplasia-Clinical Perspectives from an Ocular Oncologist. Conference. Orbit and Ocular Neoplasms. Houston, TX, US.
115. 2010. Malignant Melanoma. Conference. Malignant Melanoma. Ft. Lauderdale, FL, US.
116. 2010. Retinoblastoma. Conference. Retinoblastoma. Los Angeles, CA, US.
117. 2009. Update on Uveal Melanoma. Conference. Cosponsored by the Sociedad Panamericana de Oncologis Oftalmologica. San Francisco, CA, US.
118. 2009. Pediatric Leukocoria: A Primer. Conference. Pediatric Leukocoria: A Primer. San Francisco, CA, US.
119. 2009. Understanding Brachytherapy for Uveal Melanoma. Conference. Understanding Brachytherapy for Uveal Melanoma. San Francisco, CA, US.
120. 2009. Update from the ICOO 2009 Meeting. Conference. Update from the ICOO 2009 Meeting. Dallas, TX, US.
121. 2009. Ultrasound of the Eye: Cancer and Other Pathology. Conference. Ultrasound of the Eye: Cancer and Other Pathology. Houston, TX, US.
122. 2009. Proton Therapy: Applications for Intraocular and Orbital Tumors. Conference. Orbital & Adnexal Oncology/Oculoplastic Surgery Conference. Houston, TX, US.
123. 2009. Multidisciplinary Management of Retinoblastoma: Beyond Enucleation as the Only Treatment Option. Conference. Multidisciplinary Approach, Orbital & Adnexal Oncology/Oculoplastic Surgery Conference. Houston, TX, US.
124. 2008. Incorporating Cancer Staging Into Your Practice. Conference. American Association of Ophthalmic Pathologists. Atlanta, GA, US.
125. 2008. Moderator: Ocular Tumors and Pathology. Conference. Moderator: Ocular Tumors and Pathology. Atlanta, GA, US.
126. 2008. Multicenter Clinical Trials in Ocular Oncology. Conference. Multicenter Clinical Trials in Ocular Oncology. Atlanta, GA, US.
127. 2008. Brachytherapy for Uveal Melanoma Made Easy. Conference. European Society of Ophthalmology. Atlanta, GA, US.
128. 2007. LEO Clinical Update Course on Ocular Oncology, Sections of Metastatic Disease to the Eye & Conjunctival Tumors. Conference. LEO Clinical Update Course on Ocular Oncology, Sections of Metastatic Disease to the Eye & Conjunctival Tumors. New Orleans, LA, US.
129. 2007. AAO Course: Ophthalmic Radiation Oncology Made Ridiculously Simple. Conference. AAO Course: Ophthalmic Radiation Oncology Made Ridiculously Simple. New Orleans, LA, US.
130. 2007. AAO Course: Five Simple Steps to Tumor Diagnosis. Conference. AAO Course: Five Simple Steps to Tumor Diagnosis. New Orleans, LA, US.
131. 2007. A Proposal for a Prospective Database for Children with Retinoblastoma. Conference. A Proposal for a Prospective Database for Children with Retinoblastoma. Denver, CO, US.
132. 2007. Poster Presentation: Microphthalmia with Orbital Cyst: Features Unique to Adult Presentation. Conference. Poster Presentation: Microphthalmia with Orbital Cyst: Features Unique to Adult Presentation. Ft. Lauderdale, FL, US.
133. 2006. AAO Course: Ophthalmic Radiation Oncology Made Ridiculously Simple. Conference. AAO Course: Ophthalmic Radiation Oncology Made Ridiculously Simple. Las Vegas, NV, US.
134. 2006. AAO Course: Five Simple Steps to Tumor Diagnosis. Conference. AAO Course: Five Simple Steps to Tumor Diagnosis. Las Vegas, NV, US.
135. 2006. LEO Clinical Update Course on Ocular Oncology. Conference. Sections of Metastatic Disease to the Eye & Conjunctival Tumors. Las Vegas, NV, US.
136. 2006. Retinoblastoma 2006: A Decade of Advances. Conference. Retinoblastoma 2006: A Decade of Advances. Las Vegas, NV, US.
137. 2006. Poster Presentation, Baseline Neuro-Imaging in the Management of Retinoblastoma: Has the Standard of Care Changed?. Conference. Poster Presentation, Baseline Neuro-Imaging in the Management of Retinoblastoma: Has the Standard of Care Changed?. Las Vegas, NV, US.
138. 2006. Poster Presentation, Disparities in the Management of Intraocular Retinoblastoma Treated with Primary Chemotherapy. Conference. Poster Presentation, Disparities in the Management of Intraocular Retinoblastoma Treated with Primary Chemotherapy. Las Vegas, NV, US.
139. 2006. Ocular Melanoma- Key Issues for the Ophthalmic Technician. Conference. Ocular Melanoma- Key Issues for the Ophthalmic Technician. Las Vegas, NV, US.
140. 2006. Poster Presentation, Systemic Malignancies Metastatic to the Conjunctiva. Conference. Poster Presentation, Systemic Malignancies Metastatic to the Conjunctiva. Ft. Lauderdale, FL, US.
141. 2005. AAO Course: Retinoblastoma 2005. Conference. AAO Course: Retinoblastoma 2005. Chicago, IL, US.
142. 2005. AAO Course: Surgical Path-Onc: Bridging the Gap from the Surgeon to the Pathologist. Conference. AAO Course: Surgical Path-Onc: Bridging the Gap from the Surgeon to the Pathologist. Chicago, IL, US.
143. 2005. AAO Course: Challenges in the Cancer Patient: Clinical Pearls from a Cancer Hospital. Conference. AAO Course: Challenges in the Cancer Patient: Clinical Pearls from a Cancer Hospital. Chicago, IL, US.
144. 2005. AAO Course: Ophthalmic Radiation Oncology Made Ridiculously Simple. Conference. AAO Course: Ophthalmic Radiation Oncology Made Ridiculously Simple. Chicago, IL, US.
145. 2005. Radiation Therapy to the Eye, Indications & Complications. Conference. Radiation Therapy to the Eye, Indications & Complications. Chicago, IL, US.
146. 2005. Ocular Melanoma- Key Issues for the Ophthalmic Technician. Conference. Ocular Melanoma- Key Issues for the Ophthalmic Technician. Chicago, IL, US.
147. 2004. AAO Course: Retinoblastoma 2004. Conference. AAO Course: Retinoblastoma 2004. New Orleans, LA, US.
148. 2004. AAO Course: Diagnostic challenges in the cancer patient: Clinical pearls from a cancer hospital. Conference. AAO Course: Diagnostic challenges in the cancer patient: Clinical pearls from a cancer hospital. New Orleans, LA, US.
149. 2004. Ocular Melanoma-Key Issues for the Ophthalmic Technician. Conference. Ocular Melanoma-Key Issues for the Ophthalmic Technician. New Orleans, LA, US.
150. 2004. Diagnosis and Management of Ocular Melanoma. Conference. Diagnosis and Management of Ocular Melanoma. New Orleans, LA, US.
151. 2004. Poster Presentation, Asymmetric Microvascular Retinopathy in a Diabetic Treated with Ocular Radiotherapy. Conference. Poster Presentation, Asymmetric Microvascular Retinopathy in a Diabetic Treated with Ocular Radiotherapy, US.
152. 2004. Clinical Use of Episcleral Brachytherapy for Intraocular Tumors. Conference. Clinical Use of Episcleral Brachytherapy for Intraocular Tumors. Houston, TX, US.
153. 2003. Ocular Oncology: Cancers that affect the eye. Conference. Ocular Oncology: Cancers that affect the eye. Anaheim, CA, US.
154. 2003. AAO Course: Retinoblastoma 2003. Conference. AAO Course: Retinoblastoma 2003. Anaheim, CA, US.
155. 2003. AAO Course: Diagnostic challenges in the cancer patient: Clinical pearls from a cancer hospital. Conference. AAO Course: Diagnostic challenges in the cancer patient: Clinical pearls from a cancer hospital. Anaheim, CA, US.
156. 2003. AAO Course: Ethical issues in randomized trials. Conference. AAO Course: Ethical issues in randomized trials. Anaheim, CA, US.
157. 2003. Orbital Tumors. Conference. Orbital Tumors. Anaheim, CA, US.
158. 2003. Poster Presentation, Secondary Acute Myelogenous Leukemia in Retinoblastoma Patients: Is Chemotherapy a Factor?. Conference. Poster Presentation, Secondary Acute Myelogenous Leukemia in Retinoblastoma Patients: Is Chemotherapy a Factor?. Anaheim, CA, US.
159. 2002. AAO Course: Diagnostic challenges in the cancer patient: Clinical pearls from a cancer hospital. Conference. AAO Course: Diagnostic challenges in the cancer patient: Clinical pearls from a cancer hospital. Orlando, FL, US.
160. 2002. AAO Course: Examining the patient with breast cancer: Ocular complications and toxicities. Conference. AAO Course: Examining the patient with breast cancer: Ocular complications and toxicities. Orlando, FL, US.
161. 2002. Unique presentations of ocular metastatic disease. Conference. University of Pennsylvania. Philadelphia, PA, US.
162. 2001. AAO Course: Examining the patient with breast cancer: Ocular complications and toxicities. Conference. AAO Course: Examining the patient with breast cancer: Ocular complications and toxicities. New Orleans, LA, US.
163. 2001. Ocular manifestations of malignant disease. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
164. 2001. Treating retinoblastoma when chemotherapy fails. Conference. University of Pennsylvania. Philadelphia, PA, US.
165. 2000. AAO Course: Management of systemic malignancies metastatic to the eye and orbit. Conference. AAO Course: Management of systemic malignancies metastatic to the eye and orbit. Dallas, TX, US.
166. 2000. AAO Course: Examining the patient with breast cancer: Ocular complications and toxicities. Conference. AAO Course: Examining the patient with breast cancer: Ocular complications and toxicities. Dallas, TX, US.
167. 1999. Poster Presentation, Disparities in diagnostic screening for metastatic uveal melanoma. Conference. Poster Presentation, Disparities in diagnostic screening for metastatic uveal melanoma. Orlando, FL, US.
168. 1999. AAO Course: Examining the patient with breast cancer: Ocular complications and toxicities. Conference. AAO Course: Examining the patient with breast cancer: Ocular complications and toxicities. Orlando, FL, US.
169. 1999. AAO Course: Management of systemic malignancies metastatic to the eye and orbit. Conference. AAO Course: Management of systemic malignancies metastatic to the eye and orbit. Orlando, FL, US.
170. 1999. Adult versus pediatric choroidal metastasis: Are they really the same entity?. Conference. Adult versus pediatric choroidal metastasis: Are they really the same entity?. San Francisco, CA, US.
171. 1997. Medicare, HMOs and the expanding scope of optometric practice. What is the future of ophthalmology?. Conference. Department of Ophthalmology, University of Pennsylvania. Philadelphia, PA, US.
172. 1996. Poster Presentation, The topography of retinoblastoma. Conference. Poster Presentation, The topography of retinoblastoma. San Francisco, CA, US.

International Presentations

1. 2025. Retinal Hemangioma and Von Hippel Lindau. Invited. Pan American Congress of Ophthalmology 36th. Bogota, CO.
2. 2025. Adjuvant high dose intravitreal topotecan in the management of macular retinoblastoma in a 2-month-old. Invited. 59th Ophthalmic Oncology Group Meeting (OOG). Genoa, IT.
3. 2025. Role of aspirin in preventing carboplatin induced vascular thrombosis following intra-arterial chemotherapy (IAC). Invited. 59TH Ophthalmic Oncology Group Meeting (OOG). Genova, IT.
4. 2025. Recurrent ciliochoroidal retinoblastoma in a 9-year-old with 13q deletion. Invited. 59th Ophthalmic Oncology Group Meeting (OOG). Genova, IT.
5. 2025. Ocular Oncology Future Perspective. Panelist. Ophthalmology Conclave - Virtual Meeting. Houston, US.
6. 2025. Ocular Oncology Future Perspective - Symposium III. Invited. Ophthalmology Conclave -Virtual Meeting. Virtual, US.
7. 2024. Primary Conjunctival Rhabdomyosarcoma in Two Pediatric Patients. Invited. International Society of Ocular Oncology. Goa, IN.
8. 2024. Presentation of Medals to Dr. Geeta K. Vumganti and Dr. Vijar Anand P. Reddy. Invited. International Society of Ocular Oncology. Goa, IN.
9. 2024. Liquid Biopsy Analysis of the Aqueous Humor in a Xenograft Orthotopic Rabbit Model of Retinoblastoma Treated with Intra-Arterial Chemotherapy (IAC). Invited. International Society of Ocular Oncology. Goa, IN.
10. 2024. Presentation of Jerry Shields Medal to Dr. Katherine Paton. Invited. International Society of Ocular Oncology. Goa, IN.
11. 2024. Liquid Biopsy - a vision for curing uveal melanoma. Invited. Mexican Retina Conference. Yucatan Merida, MX.
12. 2024. Retinoblastoma controversies and trends. Invited. Yucatan Merida, MX.
13. 2024. Practical considerations and tricks when planning ocular brachytherapy. Invited. Yucatan Merida, MX.
14. 2024. The Role of Immune & Targeted Therapy in Cancer Management. Invited. World Ophthalmology Congress 2024. Vancouver, CA.
15. 2024. Update on Treatment for Metastatic Uveal Melanoma. Invited. World Ophthalmology Congress 2024. Vancouver, CA.
16. 2024. Trans Atlantic Collaboration in Retinoblastoma Between COG and Euro-Retinblastoma. Invited. European Retinoblastoma Group. Athens, GR.
17. 2023. Its in the liquid: How ancillary studoes om clinical trials will cure eye cancer. Invited. Ocular Oncology Day. Sienna, IT.
18. 2022. Stallard Lecture: Introduction to Professor Kivela. Conference. Stallard Lecture: Introduction to Professor Kivela. Leiden, NL.
19. 2022. Poster Presentation: Metastatic risk factors associated with Class 1A uveal melanoma patients. Conference. Poster Presentation: Metastatic risk factors associated with Class 1A uveal melanoma patients. Leiden, NL.
20. 2022. Poster Presentation: Impact of choroidal invasion on survival of retinoblastoma using a US national database. Conference. Poster Presentation: Impact of choroidal invasion on survival of retinoblastoma using a US national database. Leiden, NL.
21. 2022. Impact of chemotherapy on secondary primary malignancies in patients with germline retinoblastoma. Conference. International Society of Ocular Oncology. Leiden, NL.
22. 2022. Opening Ceremony. Conference. Opening Ceremony. Leiden, NL.
23. 2022. Personalized Cancer Care: The Future of Oncology has Arrived. Conference. Personalized Cancer Care: The Future of Oncology has Arrived. Paris, FR.
24. 2019. Medico-Legal Issues in Ocular Oncology: Personal Experience. Conference. Medico-Legal Issues in Ocular Oncology: Personal Experience. Siena, IT.
25. 2019. Keynote Lecture: Intraarterial Chemotherapy. Conference. Keynote Lecture: Intraarterial Chemotherapy. Siena, IT.
26. 2019. Adjuvant and metastatic therapeutic options in uveal melanoma. Conference. Adjuvant and metastatic therapeutic options in uveal melanoma. Cancun, MX.
27. 2019. Summary of COG results in retinoblastoma. Conference. Summary of COG results in retinoblastoma. Cancun, MX.
28. 2019. Poster Presentation: Angiogenic factors affect retinoblastoma invasiveness and stem cell gene expression. Poster. Poster Presentation: Angiogenic factors affect retinoblastoma invasiveness and stem cell gene expression. Vancouver, CM.
29. 2018. Treatment of Primary and Metastatic Uveal Melanoma. Conference. Ocular Oncogenesis and Oncology Conference. Lisbon, PT.
30. 2018. Approach to a Patient with Uveal Melanoma in 2018. Conference. Approach to a Patient with Uveal Melanoma in 2018. Barcelona, ES.
31. 2018. The AAOOP Consensus Statement on Retinoblastoma: Are they reasonable guidelines for European Centers. Conference. The AAOOP Consensus Statement on Retinoblastoma: Are they reasonable guidelines for European Centers. Sienna, IT.
32. 2018. Can Enucleation Cure Metastatic Uveal Melanoma?. Conference. Can Enucleation Cure Metastatic Uveal Melanoma?. Sienna, IT.
33. 2017. Retinoblastoma- How to save more lives in Latin America. Conference. Retinoblastoma- How to save more lives in Latin America. Lima, PE.
34. 2017. Intraocular Tumors. Conference. Intraocular Tumors. Sydney, AU.
35. 2016. Cytology of aqueous fluid and ocular washings following intravitreal injection of chemotherapy for retinoblastoma. Conference. Cytology of aqueous fluid and ocular washings following intravitreal injection of chemotherapy for retinoblastoma. Siena, IT.
36. 2016. Toxicities reported with intra-arterial chemotherapy for retinoblastoma. Conference. Toxicities reported with intra-arterial chemotherapy for retinoblastoma. Siena, IT.
37. 2016. Mutational analysis in a patient with uveal and cutaneous melanoma. Conference. Mutational analysis in a patient with uveal and cutaneous melanoma. Siena, IT.
38. 2015. The Children's Oncology Group (COG) Trial for Retinoblastoma using Chemotherapy. Conference. The Children's Oncology Group (COG) Trial for Retinoblastoma using Chemotherapy. Siena, IT.
39. 2015. A Case of Intra-Artery Chemotherapy Accessed Through The Middle Meningeal Artery Via Meningo-Ophthalmic Communication. Conference. A Case of Intra-Artery Chemotherapy Accessed Through The Middle Meningeal Artery Via Meningo-Ophthalmic Communication. Siena, IT.
40. 2015. Late Presentation of Retinoblastoma In a Teenager with Aicardi Syndrome. Conference. Late Presentation of Retinoblastoma In a Teenager with Aicardi Syndrome. Siena, IT.
41. 2015. Unique Cases and Management of Metastatic Choroidal Tumors. Conference. Unique Cases and Management of Metastatic Choroidal Tumors. Puerto Vallarta, MX.
42. 2015. Detection and Management of Primary Uveal Melanoma. Conference. Detection and Management of Primary Uveal Melanoma. Puerto Vallarta, MX.
43. 2015. Intra-arterial and intra vitreal Chemotherapy: Options with risk and benefits. Conference. Intra-arterial and intra vitreal Chemotherapy: Options with risk and benefits. Puerto Vallarta, MX.
44. 2015. Treatment Options for Metastatic High Risk Uveal Melanoma. Conference. Treatment Options for Metastatic High Risk Uveal Melanoma. Puerto Vallarta, MX.
45. 2015. Indications for enucleation for retinoblastoma. Conference. Indications for enucleation for retinoblastoma. Paris, FR.
46. 2014. Poster Presentation: Uveal Melanoma Tumor Size Correlated with Gene expression Profiling: the MD Anderson Experience. Conference. Poster Presentation: Uveal Melanoma Tumor Size Correlated with Gene expression Profiling: the MD Anderson Experience. Madrid, ES.
47. 2014. Screening For Metastases Is Useless. Conference. Screening For Metastases Is Useless. London, GB.
48. 2014. International Collaborative Trials in Retinoblastoma. Conference. International Collaborative Trials in Retinoblastoma. Tokyo, JP.
49. 2013. PAAO Course: Intravitreal chemotherapy for retinoblastoma: Worth consideration or too dangerous?. Conference. PAAO Course: Intravitreal chemotherapy for retinoblastoma: Worth consideration or too dangerous?. Rio De Janeiro, BR.
50. 2013. PAAO Course: COG Trials. Conference. PAAO Course: COG Trials. Rio De Janeiro, BR.
51. 2013. PAAO Course: Chemotherapy: Intravenous. Conference. PAAO Course: Chemotherapy: Intravenous. Rio De Janeiro, BR.
52. 2013. PAAO Course: Interesting Case Presentations 5. Conference. PAAO Course: Interesting Case Presentations 5. Rio De Janeiro, BR.
53. 2013. Splenic involvement as the first site of distant metastasis from a primary posterior uveal melanoma. Conference. Splenic involvement as the first site of distant metastasis from a primary posterior uveal melanoma. Ivalo, FI.
54. 2013. Modeling clinical trials for uveal melanoma using the gene expression profiling (GEP) status. Conference. Modeling clinical trials for uveal melanoma using the gene expression profiling (GEP) status. Ivalo, FI.
55. 2011. Poster Presentation, Uveal melanoma clinical trials at MD Anderson Cancer Center. Conference. Poster Presentation, Uveal melanoma clinical trials at MD Anderson Cancer Center. Buenos Aires, AR.
56. 2011. Spontaneous ischemia and pigment release in an advanced case of retinoblastoma. Conference. Spontaneous ischemia and pigment release in an advanced case of retinoblastoma. Buenos Aires, AR.
57. 2011. Seven-years-old boy with persistent painful red rye and pars plana lesion. Conference. Seven-years-old boy with persistent painful red rye and pars plana lesion. Buenos Aires, AR.
58. 2011. Poster Presentation, High risk histopathology following intra-arterial (IA) chemotherapy for retinoblastoma. Conference. Poster Presentation, High risk histopathology following intra-arterial (IA) chemotherapy for retinoblastoma. Buenos Aires, AR.
59. 2011. Poster Presentation, Diffuse infiltrating retinoblastoma after chemoreduction failure. Conference. Poster Presentation, Diffuse infiltrating retinoblastoma after chemoreduction failure. Buenos Aires, AR.
60. 2011. High risk histopathology following intrarterial (IA) chemotherapy for retinoblastoma. Conference. High risk histopathology following intrarterial (IA) chemotherapy for retinoblastoma. Buenos Aires, AR.
61. 2011. Diffuse infiltrating retinoblastoma after chemoreduction failure. Conference. Diffuse infiltrating retinoblastoma after chemoreduction failure. Buenos Aires, AR.
62. 2011. Assessment of post-operative vomiting in retinoblastoma patients and their siblings undergoing eye exams under anesthesia. Conference. Assessment of post-operative vomiting in retinoblastoma patients and their siblings undergoing eye exams under anesthesia. Buenos Aires, AR.
63. 2011. Proton Therapy for recurrent locally advanced retinoblastoma: combined results from The Retinoblastoma Center of Houston & Indiana University. Conference. Proton Therapy for recurrent locally advanced retinoblastoma: combined results from The Retinoblastoma Center of Houston & Indiana University. Buenos Aires, AR.
64. 2011. GNAQ/11 Mutant dependent uveal melanoma-sensitivity to MEK and PI3K inhibition. Conference. GNAQ/11 Mutant dependent uveal melanoma-sensitivity to MEK and PI3K inhibition. Buenos Aires, AR.
65. 2011. Mystery case presentation and discussion. Conference. Mystery case presentation and discussion. Buenos Aires, AR.
66. 2011. Current perspectives and patient care impact issues in the practice of ocular pathology; The ocular oncologist's expectations from the pathology service. Conference. Current perspectives and patient care impact issues in the practice of ocular pathology; The ocular oncologist's expectations from the pathology service. Geneva, CH.
67. 2011. Management of difficult cases in ocular oncology; The pathologist always has the last word. Three tumors-one eye. Conference. Management of difficult cases in ocular oncology; The pathologist always has the last word. Three tumors-one eye. Geneva, CH.
68. 2011. Intra-arterial chemotherapy for retinoblastoma: current perspective in 2011. Conference. Intra-arterial chemotherapy for retinoblastoma: current perspective in 2011. Geneva, CH.
69. 2011. Intra-arterial chemotherapy for retinoblastoma: current perspective in 2011; Historical perspective: from New York to Japan and back to New York. Conference. Intra-arterial chemotherapy for retinoblastoma: current perspective in 2011; Historical perspective: from New York to Japan and back to New York. Geneva, CH.
70. 2011. Intra-arterial chemotherapy for retinoblastoma: current perspective in 2011; Opportunities for multi-center trials for IA. Conference. Intra-arterial chemotherapy for retinoblastoma: current perspective in 2011; Opportunities for multi-center trials for IA. Geneva, CH.
71. 2011. Update in brachytherapy for uveal melanoma; Episcleral radioactive plaques. Conference. Update in brachytherapy for uveal melanoma; Episcleral radioactive plaques. Geneva, CH.
72. 2010. Ocular adnexal lymphoma. Conference. Federal University of Sao Paulo. Sao Paulo, BR.
73. 2010. Differential Diagnosis of Retinoblastoma. Conference. Federal University of Sao Paulo. Sao Paulo, BR.
74. 2010. PAM and melanoma. Conference. Federal University of Sao Paulo. Sao Paulo, BR.
75. 2009. Current Management & Controversies in the Management of Retinoblastoma. Conference. Federal University- Department of Ophthalmology. Sao Paulo, BR.
76. 2009. Creation of a Retinoblastoma center in Texas. Conference. Albert Einstein Hospital. Sao Paulo, BR.
77. 2009. Current Treatment and Treatment Controversies. Conference. International Network for Cancer Treatment and Research. Sao Paulo, BR.
78. 2009. What's new on Retinoblastoma treatment. Conference. Albert Einstein Hospital. Sao Paulo, BR.
79. 2009. Children's Oncology Group (COG) clinical trials in retinoblastoma: an update from the Children's Oncology Group. Conference. Children's Oncology Group (COG) clinical trials in retinoblastoma: an update from the Children's Oncology Group. Cambridge, GB.
80. 2009. Evaluation of the radiation exposure of angiography for intra-arterial chemotherapy administration for retinoblastoma. Conference. Evaluation of the radiation exposure of angiography for intra-arterial chemotherapy administration for retinoblastoma. Cambridge, GB.
81. 2009. A multi-center model for the management of retinoblastoma: a virtual RB center. Conference. A multi-center model for the management of retinoblastoma: a virtual RB center. Cambridge, GB.
82. 2009. Apparent cancer cells not derived from the malignant clone in retinoblastoma tumors. Conference. Apparent cancer cells not derived from the malignant clone in retinoblastoma tumors. Cambridge, GB.
83. 2009. Pediatric glaucoma treated with seton placement in eyes harboring medulloepithelioma. Conference. Pediatric glaucoma treated with seton placement in eyes harboring medulloepithelioma. Cambridge, GB.
84. 2009. Ocular Complication in the Cancer Patient. Conference. Tianjin Cancer Center. Tianjin, CN.
85. 2009. Introduction to Ocular Oncology at MD Anderson Cancer Center. Conference. Tianjin Cancer Center. Tianjin, CN.
86. 2009. Ophthalmic complications in the cancer patient (including ocular metastasis). Conference. Tiajin Eye Hospital. Tiajin, CN.
87. 2009. Management of uveal melanoma and conjunctival tumors. Conference. Tianjin Eye Hospital. Tianjin, CN.
88. 2009. Retinoblastoma-Part Two-Treatment toxicities and advances in research. Conference. Tianjin Eye Hospital. Tianjin, CN.
89. 2009. Retinoblastoma- Part One-Current approaches and treatment strategies. Conference. Tianjin Eye Hospital. Tianjin, CN.
90. 2009. Ongoing Investigation Protocols for Intraocular Tumors. Conference. Ongoing Investigation Protocols for Intraocular Tumors. Lima, PE.
91. 2009. Second non-ocular tumors in RB survivors. Conference. Second non-ocular tumors in RB survivors. Lima, PE.
92. 2009. Direct Intra-arterial Chemotherapy in RB. Conference. Direct Intra-arterial Chemotherapy in RB. Lima, PE.
93. 2007. Multifocal ERG, OCT, and ICG in a Patient with CNS Lymphoma and Visual Loss. Conference. Multifocal ERG, OCT, and ICG in a Patient with CNS Lymphoma and Visual Loss. Siena, IT.
94. 2007. Asymmetric Administration of Adjuvant External Beam Radiotherapy (EBRT) Following Systemic & Periocular Chemotherapy in a Patients with Bilateral Group D (R-E VB) Retinoblastoma. Conference. Asymmetric Administration of Adjuvant External Beam Radiotherapy (EBRT) Following Systemic & Periocular Chemotherapy in a Patients with Bilateral Group D (R-E VB) Retinoblastoma. Siena, IT.
95. 2007. Disparities in the Management of Retinoblastoma Treated by Ocular Oncologists. Conference. Disparities in the Management of Retinoblastoma Treated by Ocular Oncologists. Siena, IT.
96. 2007. Proposal for the Treatment of Children with Recurrent and Refractory Retinoblastoma with Doxercalciferol. Conference. Proposal for the Treatment of Children with Recurrent and Refractory Retinoblastoma with Doxercalciferol. Siena, IT.
97. 2007. Secondary AML(sAML) in Patients with Retinoblastoma Treated by Ocular Oncologists. Conference. Secondary AML(sAML) in Patients with Retinoblastoma Treated by Ocular Oncologists. Siena, IT.
98. 2007. Unilateral Retinoblastoma Presenting in a Child with Congenital Glaucoma and Down's Syndrome. Conference. Unilateral Retinoblastoma Presenting in a Child with Congenital Glaucoma and Down's Syndrome. Siena, IT.
99. 2007. Intensity Modulated Proton Beam Radiotherapy (IMPT): Is This New Technique Applicable to Retinoblastoma and Other Pediatric Ocular Tumors?. Conference. Intensity Modulated Proton Beam Radiotherapy (IMPT): Is This New Technique Applicable to Retinoblastoma and Other Pediatric Ocular Tumors?. Siena, IT.
100. 2007. Poster Presentation: Retinoblastoma Presenting in a Child with Axenfeld's Anomaly. Conference. Poster Presentation: Retinoblastoma Presenting in a Child with Axenfeld's Anomaly. Siena, IT.
101. 2007. Poster Presentation: Bioimmunotherapy for Metastatic Melanoma to the Choroids. Conference. Poster Presentation: Bioimmunotherapy for Metastatic Melanoma to the Choroids. Siena, IT.
102. 2007. Simultaneous Choroidal Infiltration of the Uveal with Primary Melanoma and Metastatic Chronic Lymphocytic Leukemia. Conference. Simultaneous Choroidal Infiltration of the Uveal with Primary Melanoma and Metastatic Chronic Lymphocytic Leukemia. Siena, IT.
103. 2007. Metastatic Prostate Cancer to the Choroid Responding to Androgen Therapy Alone. Conference. Metastatic Prostate Cancer to the Choroid Responding to Androgen Therapy Alone. Siena, IT.
104. 2007. Orbital Sarcoma Treated with Fractionated Proton Beam Radiotherapy. Conference. Orbital Sarcoma Treated with Fractionated Proton Beam Radiotherapy. Siena, IT.
105. 2007. Rapid Fire Case Presentation Session. Conference. Rapid Fire Case Presentation Session. Siena, IT.
106. 2007. PAAO Course: Clinical Presentation and Current Therapy of Intraocular Lymphoma. Conference. PAAO Course: Clinical Presentation and Current Therapy of Intraocular Lymphoma. Cancun, MX.
107. 2007. PAAO Course: Focal Therapy for Retinoblastoma. Conference. PAAO Course: Focal Therapy for Retinoblastoma. Cancun, MX.
108. 2007. Ocular Oncology Sub-Specialty Day: Secondary Complications of Retinoblastoma Treated with Chemotherapy. Conference. Ocular Oncology Sub-Specialty Day: Secondary Complications of Retinoblastoma Treated with Chemotherapy. Cancun, MX.
109. 2005. Asymptomatic Peritoneal Mesothelioma Diagnosed in a Patient with Uveal Melanoma. Conference. Asymptomatic Peritoneal Mesothelioma Diagnosed in a Patient with Uveal Melanoma. Whistler, CA.
110. 2005. Sequential Ruthenium Brachytherapy as an Alternative to External Beam Radiation Therapy for Recurrent Retinoblastoma. Conference. Sequential Ruthenium Brachytherapy as an Alternative to External Beam Radiation Therapy for Recurrent Retinoblastoma. Whistler, CA.
111. 2005. Salvage Techniques for Recurrent Retinoblastoma Following Chemotherapy: Can We Do Better with Proton Beam Radiation?. Conference. Salvage Techniques for Recurrent Retinoblastoma Following Chemotherapy: Can We Do Better with Proton Beam Radiation?. Whistler, CA.
112. 2005. Revisiting the Significance of Tumor Location in the Management of Retinoblastoma with Chemotherapy: What can we learn from the Response in Eyes with Multifocal Disease?. Conference. Revisiting the Significance of Tumor Location in the Management of Retinoblastoma with Chemotherapy: What can we learn from the Response in Eyes with Multifocal Disease?. Whistler, CA.
113. 2005. A Multi-disciplinary Cancer Center as a Model for VHL Screening and Management. Conference. A Multi-disciplinary Cancer Center as a Model for VHL Screening and Management. Whistler, CA.
114. 2004. Independent Dosimetric Verification of Bebig Ruthenium-106 Plaques. Conference. Independent Dosimetric Verification of Bebig Ruthenium-106 Plaques. Hyderabad, IN.
115. 2004. Asymmetric Response of Bilateral Uveal Metastasis Treated with Identical Therapy. Conference. Asymmetric Response of Bilateral Uveal Metastasis Treated with Identical Therapy. Hyderabad, IN.
116. 2003. Secondary AML in patients with retinoblastoma. Conference. Secondary AML in patients with retinoblastoma. Paris, FR.
117. 2002. Recurrent leptomeningeal gastric carcinoma presenting as uveitis. Conference. Recurrent leptomeningeal gastric carcinoma presenting as uveitis. Sydney, AU.
118. 2002. Vitreous relapse following primary chemotherapy for retinoblastoma. Conference. Vitreous relapse following primary chemotherapy for retinoblastoma. Sydney, AU.
119. 2002. Leiomyosarcoma of the sympathetic chain metastatic to conjunctiva. Conference. Leiomyosarcoma of the sympathetic chain metastatic to conjunctiva. Sydney, AU.
120. 2001. Retinoblastoma treated with primary chemotherapy alone: The significance of tumor size, location and age. Conference. Retinoblastoma treated with primary chemotherapy alone: The significance of tumor size, location and age. Amsterdam, NL.
121. 2001. Secondary leukemia and death following treatment of intraocular retinoblastoma with primary chemotherapy. Conference. Secondary leukemia and death following treatment of intraocular retinoblastoma with primary chemotherapy. Amsterdam, NL.
122. 2001. Conjunctival melanoma metastatic to the contralateral eye. Conference. Conjunctival melanoma metastatic to the contralateral eye. Amsterdam, NL.
123. 2000. Advances in retinoblastoma research. Conference. Advances in retinoblastoma research. London, GB.
124. 1999. Pediatric uveal metastasis: Features and characteristics of a rare entity. Conference. Pediatric uveal metastasis: Features and characteristics of a rare entity. Stockholm, SE.
125. 1999. Choroidal metastatic disease: New insights from pediatric cases. Conference. Choroidal metastatic disease: New insights from pediatric cases. Victoria, GB.
126. 1999. Poster Presentation, Ocular toxicities associated with breast cancer management. Conference. Poster Presentation, Ocular toxicities associated with breast cancer management. Stockholm, SE.

Formal Peers

1. 2022. Ocular Oncologists Perspective. Invited. Houston, TX, US.
2. 2022. Advances in Personalized Care in Ocular Oncology. Invited. Memphis, TN, US.
3. 2022. Retinoblastoma 2022: The future of personalized cancer management is here. Invited. Austin, TX, US.
4. 2021. Visiting Professor: Lessons learned from my biggest research failures. Invited. Houston, TX, US.
5. 2021. Visiting Professor: Twenty years of Prospective Multi-Center Trials for Retinoblastoma: What have we learned?. Invited, US.
6. 2019. Visiting Professor: 2019 Calhoun Lecture at the Southeastern Conference in Ocular Oncology & Pathology. Invited. Atlanta, GA, US.
7. 2018. Ophthalmic Pathology- an Ocular Oncologist Perspective. Invited. Houston, TX, US.
8. 2018. Retinoblastoma- Is there still a Role for Enucleation, and A look at Intra-Arterial and Intra-Vitreal Chemotherapy. Invited. New York, NY, US.
9. 2018. Conjunctival Tumors and Immunotherapy. Invited. New York, NY, US.
10. 2017. Echography of Tumors. Invited. Houston, TX, US.
11. 2017. Echography of Tumors. Invited. Houston, TX, US.
12. 2016. Visiting Professor: Prospective Multi-Center Trials for Retinoblastoma. Invited. San Antonio, TX, US.
13. 2013. Visiting Professor: Retinoblastoma 2013: Clinical Challenges & Future Direction. Invited. New York, NY, US.
14. 2012. Retinoblastoma: clinical challenges and future direction. Invited. Jerusalem, IL.
15. 2012. Retinoblastoma 2012: clinical challenges and future direction. Invited. Houston, TX, US.
16. 2011. Southeastern Ocular Oncology and Pathology Seminar. Invited. Atlanta, GA, US.
17. 2011. Intra-Arterial Chemotherapy for Retinoblastoma-Why It's Time for a Prospective Multi-Center Trial. Invited. Philadelphia, PA, US.
18. 2011. Update from the retinoblastoma subcommittee of the Children's Oncology Group. Invited. Philadelphia, PA, US.
19. 2011. High risk histopathology following IA chemotherapy for retinoblastoma. Invited. Philadelphia, PA, US.
20. 2011. Retinoblastoma and Other Tumors. Invited. Houston, TX, US.
21. 2011. Retinoblastoma 2011: Is Intra-Arterial Chemotherapy the Next Evolution of Primary Intraocular Care?. Invited. Temple, TX, US.
22. 2011. Controversies in Retinoblastoma. Invited. Caesars Atlantic City, NJ, US.
23. 2011. Common Manifestations of Metastatic Disease. Invited. Caesars Atlantic City, NJ, US.
24. 2011. Conjunctival Tumors. Invited. Atlantic City, NJ, US.
25. 2010. Rapidly growing intraocular mass in teenager. Invited. Philadelphia, PA, US.
26. 2010. Benefits of primary enucleation for sporadic retinoblastoma. Invited. Philadelphia, PA, US.
27. 2009. Current Controversies in the Management of Retinoblastoma. Invited. Houston, TX, US.
28. 2009. Visiting Professorship: Tianjin University. Invited. Tianjin, CN.
29. 2009. Classification of Intraocular Retinoblastoma. Invited. Galveston, TX, US.
30. 2008. Ocular Oncology. Invited. New York, NY, US.
31. 2008. Chemotherapy for Retinoblastoma: Risk and Benefit. Invited. Cleveland, OH, US.
32. 2008. Diagnosis of Uveal Melanoma. Invited. Cleveland, OH, US.
33. 2008. Visiting Professor: Retinoblastoma 2008: Past, Present and Future Directions. Invited. Philadelphia, PA, US.
34. 2008. Enucleation- Surgical Principles, Technique and Indications. Invited. Galveston, TX, US.
35. 2007. Visiting Professor: Management of Uveal Metastases. Invited. Orange County, CA, US.
36. 2007. Visiting Professor: Ocular Oncology for the General Ophthalmologist. Invited. Orange County, CA, US.
37. 2007. The Optics of Ocular Oncology. Invited. Galveston, TX, US.
38. 2007. Conjunctival Tumors: Melanoma & Squamous Cell Carcinoma. Invited. Galveston, TX, US.
39. 2007. Conjunctival Surgical Tumors. Invited. Galveston, TX, US.
40. 2007. Metabolic Disease to the Eye. Invited. Galveston, TX, US.
41. 2007. Retinoblastoma. Invited. Galveston, TX, US.
42. 2006. Retinoblastoma Treatment, Part I. Invited. Galveston, TX, US.
43. 2006. Diagnosis of Retinoblastoma. Invited. Galveston, TX, US.
44. 2006. Clinical Presentation and Differential Diagnosis of Retinoblastoma. Invited. Galveston, TX, US.
45. 2006. Epidemiology and Genetics of Retinoblastoma. Invited. Galveston, TX, US.
46. 2006. Introduction and Principles of Ocular Oncology. Invited. Galveston, TX, US.
47. 2006. Visiting Professor, Ocular Toxicities and Complications in Patients with Systemic Malignancies & Current Controversies in the Management of Retinoblastoma. Invited. Budapest, HU.
48. 2006. Ocular Oncology OKAP Review. Invited. Galveston, TX, US.
49. 2005. Visiting Professor, Ophthalmic Complications in the Oncology Patient. Invited. Cape Town, ZA.
50. 2005. Management of Orbital Cellulitis in the Cancer Patient. Invited. Galveston, TX, US.
51. 2005. Principles in Ocular Echography in Ocular Oncology. Invited. Galveston, TX, US.
52. 2005. Surgical Principles in Ocular Oncology, Part III. Invited. Galveston, TX, US.
53. 2005. Surgical Principles in Ocular Oncology, Part II. Invited. Galveston, TX, US.
54. 2005. Surgical Principles in Ocular Oncology, Part I. Invited. Galveston, TX, US.
55. 2005. Ocular Complications from Chemotherapeutic Agents. Invited. Galveston, TX, US.
56. 2005. OKAP - Ocular Oncology Review. Invited. Galveston, TX, US.
57. 2005. Principles of Radiation Therapy for Ocular, Peri-Ocular and Orbital Tumors. Invited. Galveston, TX, US.
58. 2005. Multidisciplinary Approach in the Management of Retinoblastoma. Invited. Galveston, TX, US.
59. 2005. Diagnosis and Staging of Retinoblastoma. Invited. Galveston, TX, US.
60. 2004. Visiting Professor, Ophthalmic Complications and Related Toxicities in the Cancer Patient. Invited. New York, NY, US.
61. 2004. Genetics and Epidemiology of Retinoblastoma. Invited. Galveston, TX, US.
62. 2004. Introduction to Intraocular Tumors. Invited. Galveston, TX, US.
63. 2004. Incidence and Epidemiology of Cancer in the U.S. Invited. Galveston, TX, US.
64. 2004. Optics of Ocular Oncology. Invited. Galveston, TX, US.
65. 2004. Ocular oncology Board review Part II. Invited. Galveston, TX, US.
66. 2004. Ocular oncology Board review Part I. Invited. Galveston, TX, US.
67. 2003. Pediatric orbital malignancies. Invited. Galveston, TX, US.
68. 2003. Echography of intraocular tumors. Invited. Galveston, TX, US.
69. 2003. Diagnosis and management of intraocular vascular tumors. Invited. Galveston, TX, US.
70. 2003. Intraocular metastasis. Invited. Galveston, TX, US.
71. 2003. Management of orbital cellulitis in the cancer patient. Invited. Galveston, TX, US.
72. 2003. Current management of retinoblastoma with chemotherapy. Invited. Galveston, TX, US.
73. 2003. Epidemiology and differential diagnosis of retinoblastoma. Invited. Galveston, TX, US.
74. 2003. Ophthalmology Board Review. Invited. Galveston, TX, US.
75. 2003. The Collaborative Ocular Melanoma Study. How does it impact the management of uveal melanomas?. Invited. Galveston, TX, US.
76. 2003. Therapies for posterior uveal melanomas. Invited. Galveston, TX, US.
77. 2002. Management of indeterminate melanocytic lesions of the choroid and small uveal melanomas. Invited. Galveston, TX, US.
78. 2002. Visiting Professor, Advances in the Management of Retinoblastoma: Confessions of a Junior Ocular Oncologist. Invited. New York, NY, US.
79. 2002. Choroidal Nevi: Management and Prognostic indications for growth. Invited. Galveston, TX, US.
80. 2002. Management of iris melanomas. Invited. Galveston, TX, US.
81. 2002. Non-neoplastic Diseases Resembling Iris Melanomas. Invited. Galveston, TX, US.
82. 2002. The Optics of Ocular Oncology. Invited. Galveston, TX, US.
83. 2002. Non-neoplastic Diseases Simulating Intraocular Tumors. Invited. Galveston, TX, US.
84. 2002. Ocular Oncology Board Review. Invited. Galveston, TX, US.
85. 2002. Multi-center trials in ocular oncology. Invited. Galveston, TX, US.
86. 2002. Management of Conjunctival Malignancies. Invited. Galveston, TX, US.
87. 2001. Retinoblastoma: Diagnosis and management. Invited. Galveston, TX, US.
88. 2001. Ocular Oncology Update. Invited. Galveston, TX, US.